SCHEMBL6788210

SCHEMBL6788210

CCCC[Sn](CCCC)(CCCC)c1ccccc1CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
DRD3 P35462 1/20 0.41
TSHR P16473 2/20 0.41
PTK2B Q14289 1/20 0.41
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
RECQL P46063 1/20 0.40
CASP3 P42574 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 2/20 0.38
ALDH2 P05091 1/20 0.38
ALDH3A1 P30838 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4785053 0.85 ALDH1A1 (0.56) ALDH1A1ALDH2ALDH3A1MAPT
SCHEMBL15923220 0.70 MAPT (0.62) NR1H2NR1H3TSHRGAAKDM4E
SCHEMBL4772254 0.70 L3MBTL1 (0.40) TSHRKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL29820186 0.70 PTGS1 (0.65) TSHRGAAKDM4ERECQLCASP3
SCHEMBL10304923 0.70 PTGS1 (0.65) TSHRGAAKDM4ERECQLCASP3
SCHEMBL5697024 0.70 MAPT (0.54) CASP3MEN1KMT2AALDH1A1MAPT
SCHEMBL6330232 0.69 ALDH1A1 (0.46) DRD3TSHRGAAKDM4ERECQL
SCHEMBL2480474 0.69 SLC6A4 (0.38) TSHRKDM4EMEN1KMT2ACYP3A4
SCHEMBL29511230 0.69 CHRM2 (0.61) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL149620 0.69 CHRM2 (0.61) MEN1KMT2ACYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG NR1H2 2176/4885NR1H3 2793/4885DRD3 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.